The global idiopathic pulmonary fibrosis market size was valued at USD 4.54 billion in 2024 and is projected to reach from ...
Stockhead on MSN7d
The ASX players bringing new hope to IPF sufferersIdiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...
GlobalData on MSN9h
Brainomix concludes $18m fund raise to strengthen US presenceBrainomix entered the US market in 2023 having gained several FDA clearances for modules within its stroke care platform.
She cited her mum Amy's battle with idiopathic pulmonary fibrosis, a terminal lung disease, as the reason behind her decision. 'I have a big confession to make, and if there's anyone out there ...
Katie Price is reportedly keen to marry her boyfriend JJ Slater as soon as possible amid her mum Amy's ongoing battle with ...
Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria Hoffmann-Vold, M.D., Ph.D., of Oslo University Hospital and the expert ...
Katie Price has shared a heart-breaking update on her mother, Amy, who is fighting idiopathic pulmonary fibrosis (IPF). The ...
Hosted on MSN11d
Popular health supplement shows promise in reversing lung damageA recent study from the Women’s Guild Lung Institute at Cedars-Sinai suggests that zinc could help reverse lung damage in ...
News-Medical.Net on MSN13d
Insilico Medicine's AI-driven drug Rentosertib receives official generic nameInsilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic pulmonary ...
Pliant Therapeutics has scrapped its Phase IIb Beacon-IPF trial for bexotegrast in idiopathic pulmonary fibrosis (IPF), after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback